Trial Profile
A Phase 4 12-week, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating The Safety And Efficacy Of Varenicline Tartrate (CP-526,555) 1mg BID For Smoking Cessation In Subjects With Depression
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Dec 2021
Price :
$35
*
At a glance
- Drugs Varenicline (Primary)
- Indications Smoking withdrawal
- Focus Therapeutic Use
- Sponsors Pfizer
- 22 Feb 2014 New trial record